AI-generated summary
This review summarizes the mechanisms of chronic cerebral hypoperfusion and evaluates neuromodulation approaches, including repetitive transcranial magnetic stimulation, transcranial electrical stimulation, photobiomodulation, and ultrasound. The authors report that these interventions may mitigate hypoperfusion-related brain injury and cognitive impairment, but they also describe challenges such as limited deep-target engagement and insufficient individualized dosing.
- Who or what was studied
- Chronic cerebral hypoperfusion and related vascular cognitive impairment (review; no patient population specified)
- Limits stated in the abstract
- The abstract describes a narrative review and states that clinical translation remains challenged by limited deep-target engagement, insufficient individualized dosing, and underuse of rhythm-based biomarkers.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Chronic cerebral hypoperfusion (CCH) is a major hemodynamic substrate of vascular cognitive impairment and vascular dementia, yet effective therapies with multi-target neuroprotective potential remain limited. CCH triggers a complex pathological cascade characterized by neurovascular dysfunction, white matter injury, neuroinflammation, oxidative stress, and synaptic impairment.
Methods
In this review, we summarize the major pathophysiological mechanisms of CCH and discuss current evidence supporting neuromodulation as a promising therapeutic strategy. We focus primarily on central stimulation modalities, including repetitive transcranial magnetic stimulation, transcranial electrical stimulation, photobiomodulation, and ultrasound-based neuromodulation, while also addressing selected peripheral physical modulation approaches and emerging multimodal combination strategies.
Results
Available evidence suggests that these interventions may mitigate hypoperfusion-related brain injury and cognitive impairment by targeting multiple pathophysiological mechanisms, ultimately restoring synaptic plasticity and promoting circuit- and network-level recovery. We further discuss current challenges to clinical translation, including limited deep-target engagement, insufficient individualized dosing, and the underuse of rhythm-based biomarkers.
Conclusion
Neuromodulation holds promise as a mechanistically informed and multi-target neuroprotective strategy for CCH-related cognitive impairment.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Neuromodulation, Transcranial magnetic stimulation, Photobiomodulation, Neuroinflammation, Oxidative stress, Brain injury, Dementia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.